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Abstract 
In an epidemiological study based on insurance data we described a breed-specific 
pattern of diseases in German Shepherd dogs (GSD) and confirmed that this breed 
is predisposed to immune-related disorders. A prospective study was performed in 
order to further investigate immunological changes in the GSD using a large 
number of dogs, 30 bitches and their litters, from the same kennel under well 
controlled natural conditions. Changes in fecal and serum immunoglobulins were 
followed from birth to young adult age and possible relationships between these 
parameters in dams and their offspring were identified. We also described the 
composition of gut microbiome in dogs and how it changes in different life stages 
including pregnancy, lactation and growth. The levels of serum IgE, serum IgA 
and fecal IgA increased from seven weeks of age and were then stabilized at one 
year of age, there was no relationship in immunoglobulin concentrations between 
bitches and their 7 weeks old puppies. Dogs with high fecal IgA had a better 
vaccine response indicating a favorable systemic immune status. We found 
profound differences in the gut microbiome between mothers and young dogs. 
Litter mates had a more similar fecal microbiome compared to unrelated dogs. The 
7 weeks old puppies were no more similar to the mothers than to unrelated bitches 
at partum. However, the fecal microbiome of the puppies were significantly more 
similar to their mothers than to unrelated bitches at 7 weeks postpartum. We 
observed a change in the relative abundance of different bacteria during lactation, 
and an increase of diversity from pregnancy to end of lactation. We also found that 
the diversity of fecal microbiome was affected by living environment but we were 
unable to demonstrate an effect of pre- and postnatal exposure to the chosen strain 
of probiotics. Our results provide information to an area within canine 
microbiology and immunology which is not studied before -this is the first study to 
describe the gut microbiome as well as immunoglobulins (and their relation to each 
other) in pregnant and lactating bitches and their offspring. This information is a 
needed foundation for further research on the relationship between the microbiome 
at an early age and immune function later in life and of value for the evaluation of 
interventions. 
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Abbreviations 
APC Antigen presenting cell 
CAD Canine atopic dermatitis  
CSK Chronic superficial keratitis 
DC Dendritic cell 
EPA Exocrine pancreatic acinar atrophy 
EPI Exocrine pancreatic insufficiency 
GALT Gut-associated lymphoid tissue 
GSD German Shepherd dog  
IgA Immunoglobulin A 
IgD Immunoglobulin D 
IgE Immunoglobulin E 
IgG Immunoglobulin G 
IgM Immunoglobulin M 
IL-1 Interleukin 1 
IL-6 Interleukin 6 
IL-8 Interleukin 8 
IL-10 Interleukin 10 
IL-12 Interleukin 12 
LPS Lipopolysaccharide 
MHC Major histocompatibility complex 
PAMP Pathogen-associated molecular pattern 
SLE Systemic lupus erythematosus 
TLR Toll-like receptor 
TNF-α Tumor Necrosis Factor alpha 
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1 Introduction 
The immune system is a network of cells, tissues and organs that primarily 
work to defend the body against foreign invaders such as bacteria, viruses, 
parasites and fungi. The immune system works against invaders through 
layered defences of increasing specificity.  The first line of defence are the 
mechanical or physical barriers (skin and mucosa). The next line of defence 
includes innate and acquired immunity. Innate immunity responds 
immediately, without needing to learn to recognize the invaders. In acquired 
immunity, lymphocytes meet an invader, learn how to attack it, and built up a 
memory of the specific invader so they can attack it more efficiently the next 
time they encounter it. Innate and acquired immunity interact with other 
molecules in the body fluids, including cytokines, antibodies and complement 
proteins (Janeway et al. 2005). The gut is the largest immune organ in the body 
(Chassaing et al. 2014). The gut microbes are essential for the immune system 
(Björkstén et al. 2001), for the general health, brain and even behaviour (Diaz 
Heijtz 2016). 
In order to work appropriate, the immune system must have the ability to 
distinguish between what belongs in the body (self) or what does not (non-
self). Any substances that are identified as non-self stimulate an immune 
response in the body. Immune-related disorders occur when the body generates 
an immune response against itself (autoimmune disorders), the body cannot 
generate sufficient immune response against invading organisms 
(immunodeficiency disorders), or the body react to harmless foreign antigens 
with an inappropriate immune regulation (allergic disorders). 
For humans living in industrialized countries, the prevalence of immune-
related disorders has increased rapidly the past decades (de Silva et al. 2008; 
Herbert et al. 2009) and there are indications that this is also the case in dogs. 
Since we share the same environment with the dogs, it is presumed that the 
influences of environment on the prevalence of immune-related disorders may 
be similar across these two species. 
The relation between early microbial exposure and development of the 
canine immune system is not well described. In humans, this area has evoked 
great interest in the research of prevention and treatment of chronic immune-
related disorders. The mammalian immune system is a unique example of 
symbiosis were microbes, as potential enemies, have been integrated into 
intestinal function, giving vital information to the host and protecting it from 
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hostile interventions. Microbes were there from the start of mammalian 
evolution (Ley et al. 2008). In a short time we have moved from a lifestyle 
with high load of microbial exposure to a comparable sterile environment 
which has resulted in a selection for a microbiota that do not always elicit 
balanced immune responses. 
Despite their popularity, the overall disease pattern in the German Shepherd 
dog (GSD) is not well described. Breed-specific studies of disease patterns in 
companion animals are scarce since it is difficult to obtain accurate population-
based estimates from records presented by veterinary clinics. However, there 
are indications that GSD are predisposed to a number of immune-related 
disorders compared to other breeds, (Wisselink et al. 1985; Day et al. 1986; 
Batt et al. 1991; Clark et al. 2005; Nødtvedt et al. 2006; Vilson et al. 2013). 
This predisposition is suggested to be a result of inherited defects in the 
immune system (Whitbread et al. 1984; Day et al. 1988; Batt et al. 1991; Griot-
Wenk et al. 1999). 
In this thesis, unique Swedish features have made it possible to supply 
breed and disease specific estimates on the extent of veterinary care and death 
risk through access to the database at Agria Insurance. Furthermore, we 
monitored immunological parameters in a large number of German Shepherd 
litters and their dams born and raised under well controlled conditions at the 
kennel of the Swedish Armed Forces. This breeding colony also gave us an 
opportunity to study the influences on the immune system and the gut 
microbiome from environmental factors, including probiotic supplementation, 
from an early age. 
This large and well controlled study population has given us valuable 
information about the immune system as well as the gut microbiome during 
pregnancy, lactation and during the first stage of life. This information will be 
of great importance for further studies regarding immune-stimulation and 
disease-prevention. 
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2 Aims of the thesis 
 Describe the disease patterns in GSDs in Sweden and to test the
hypothesis that GSDs are predisposed to immune-related disorders.
 Monitor changes in serum immunoglobulins from birth to young adult
age and evaluating the relationship between dams and their offspring
reared under well controlled conditions.
 Explore the development of the gut microbiome and immunological
parameters in German Shepherd dogs from puppy to adulthood and
furthermore, to study the effect of relatedness, maternal microbiome
composition and living environment in a large and well-defined
population of dogs.
 Evaluate whether administration of probiotics (Lactobacillus johnsonii
NCC533 (La1)) enhance IgG antibody responses against Canine
Distemper Virus in serum, and assess the effects on the fecal
microbiome of early age probiotic supplementation to bitches and
puppies.
The results will increase our understanding of different factors involved in the 
development of immune related disorders and potentially provide a means to 
improve the overall health of our dog population. The results may also be 
useful in comparative studies by increasing our understanding of processes 
driving the development of immune regulation and potential to prevent 
allergies and other immune related disorders. 
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3 Background 
3.1 Immune-related disorders in German Shepherd 
dogs 
The German Shepherd dog (GSD) is one of the most popular working and 
companion dog breeds worldwide (Figure 1). When compared to other breeds, 
they have higher morbidity due to immune-related disorders compared to other 
breeds, (Wisselink et al. 1985; Day et al. 1986; Batt et al; 1991; Clark et al. 
2005; Nødtvedt et al. 2006; Vilson et al. 2013). This predisposition is 
suggested to be a result of inherited defects in the immune system (Whitbread 
et al. 1984; Day et al. 1988; Batt et al. 1991; Griot-Wenk et al. 1999). 
Immune-related disorders can be divided into three major categories; 
allergy, autoimmunity and immune deficiency. Allergy and autoimmunity are 
characterized by a hyperactive immune system while immune deficiency 
occurs when the immune system is lacking parts necessary for normal function. 
Figure 1. The German Shepherd dog is predisposed to immune-related 
disorders. 
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 3.1.1 Allergic disease 
3.1.1.1 Clinical features 
The most common allergy in dogs is canine atopic dermatitis (CAD), defined 
as genetically-predisposed inflammatory and pruritic allergic skin disease 
commonly associated with IgE antibodies to environmental allergens (Olivry et 
al. 2001). The age of onset is typically between 6 months and 3 years. Initial 
clinical signs of CAD can be seasonal or nonseasonal, depending upon the 
allergens involved. Clinical signs include pruritis of the face, ears, paws, 
extremities, and/or ventrum. Some dogs have no visible primary lesions, but 
when they are present they will consist primarily of erythema.  Secondary 
lesions are common as a result of chronic pruritis and trauma and may include 
chronic inflammation, and concurrent secondary infections or microbial 
overgrowth. Otitis externa and conjunctivitis is commonly seen in atopic dogs 
(Griffin et al. 2001). 
3.1.1.2 Risk factors 
Breed predilections are well known in CAD, with a marked variation 
depending on geographical location. The top-five breeds with highest 
incidence rates in Sweden are Bull terrier, Welsh terrier, Boxer, West Highland 
white terrier and Staffordshire bullterrier. The German Shepherd dog was 
number nine in that study (Nødtvedt et al. 2006). Genome-wide analysis in 
GSD reveals associations of a locus on CFA27 with atopic dermatitis and 
haplotype association analysis from the fine-mapping data indicated 
association to the gene, plakophilin 2 (PKP2), known to be important for skin 
structure.  Low(er) IgA levels in that study were correlated to increased risk for 
atopy (Tengvall et al. 2013). 
Environmental factors such as living area and diet affect the development 
of CAD. The risk of CAD is higher in major cities in Sweden, however this 
may be biased by a higher number of dermatologists in these areas (Nødtvedt 
et al. 2006). Nødtvedt et al. (2007) showed a protective effect of feeding home-
made diets to the lactating bitch on the subsequent development of CAD in her 
offspring. It is speculated that this is a result of increased microbial exposure 
early in life, which is shown to have importance for the development of the 
immune system of the neonate. 
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3.1.2 Autoimmune disease 
In autoimmune disease is an immune response generated towards self-tissues. 
Depending on which of the self-antigens the immune response is directed 
toward, clinical signs of disease may occur and are related to the functions of 
those target tissues or organs. Autoimmune diseases are classified into organ-
specific and systemic diseases depending on where the target antigen is 
expressed. Examples of autoimmune diseases overrepresented in GSD are; 
chronic superficial keratitis (CSK), exocrine pancreatic acinar atrophy (EPA) 
and systemic lupus erythematosus (SLE). 
Chronic superficial keratitis or pannus is an autoimmune inflammation of 
the cornea that can lead to blindness. The disease can occur in any breed but 
most cases are reported in GSD (Slatter et al. 1977; Chavkin et al. 1994). The 
clinical signs are progressive, bilateral lesions in the anterior corneal stroma 
with vascularization, formation of fibrous tissue and often pigmentation at the 
chronic stage (Bedford and Longstaffe 1979). The inflammatory lesions 
involve stromal infiltration by CD4+ T lymphocytes. There is also an increased 
expression of major histocompatibility complex (MHC) class II in the cornea 
of affected dogs, which may play an important part in prolonging the 
inflammatory process in the cornea (Williams 2005). 
Exocrine pancreatic acinar atrophy is characterized by the selective atrophy 
of pancreatic acinar cells as a result of lymphocytic pancreatitis. It is the most 
common cause of exocrine pancreatic insufficiency (EPI) in dogs 
(Westermarck et al. 1993) with high predisposition in GSD (German 2012). 
Clinical signs include an increased appetite, weight loss, and voluminous soft 
stools (Westermarck et al. 1989). Exocrine pancreatic acinar atrophy is 
diagnosed through measurement of serum trypsin-like immunoreactivity (TLI) 
which is decreased in diseased dogs (Williams et al. 1988). The destruction of 
acinar tissue is largely T-cell-mediated, although some humoral mechanisms 
are involved as well (Wiberg et al. 2000; Tsai et al. 2013). 
Systemic lupus erythematosus (SLE) is an example of systemic 
autoimmune diseases in dogs. In humans, SLE is a heterogeneous disease with 
a classification based on well-defined criteria (Tan et al. 1982). In dogs, a 
consistent list of criteria does not exist –making it difficult to diagnose canine 
SLE. One hallmark of SLE is high titer of circulating antinuclear antibodies 
(ANA). In a study by Hansson-Hamlin et al. (2006), all ANA-positive dogs 
had symmetrical polyarthritis and/or myositis, lethargy, and fever. This is in 
contrast to human SLE where other organs often are involved. Thus, the canine 
disease is referred to as SLE-related disease. German Shepherd dogs were 
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clearly predominated among the ANA-positive dogs (32%) in this study. It has 
been shown that the majority of the German Shepherds with serum positive for 
ANA by indirect immunofluorescence also had an identical but unidentified 
immunodiffusion ANA-subgroup specificity which may indicate a breed-
specific disorder, reflecting a hereditary susceptibility among German 
Shepherds to a certain subtype of SLE-related disease (Hansson & Karlsson-
Parra et al. 1999).  
3.1.3 Immunodeficiency 
Immunodeficiency disorders are uncommonly reported in the dog. These are 
usually inherited and have been recognized in a number of breeds including the 
German Shepherd dog (Day et al. 1988; Batt et al. 1991; Day 1994; Chabanne 
et al. 1995). 
Selective IgA deficiency is the most common primary immunodeficiency 
disease in humans (Cunningham-rundles 1999). In most cases the disease will 
not cause any illness, but some patients have a tendency to develop recurrent 
infections at mucosal sites, autoimmune disease, allergy and gastrointestinal 
infections (Yel 2010). Low concentrations of serum IgA have been reported in 
selected dog breeds, including the GSD (Whitbread et al. 1984), Beagle 
(Felsburg et al. 1985) and Shar-Pei (Moroff et al. 1986). Olsson et al. (2014) 
identified eight breeds that could be classified as IgA deficient according to the 
human cut off value for IgA deficiency. The clinical signs in dogs have been 
reported to resemble the human disease by recurrent infections and immune 
mediated disease (Felsburg et al. 1985; Moroff et al. 1986). Tengvall et al. 
(2013) studied a large cohort of GSD in Sweden and found significantly lower 
serum IgA levels in dogs with atopic dermatitis compared to the control dogs, 
suggesting a functional role of IgA in the aetiology of canine atopic dermatitis. 
3.2 Immunoglobulins –basic concepts 
Antibodies were the first product of the adaptive immune response to be 
discovered. They are found in the body fluids and secreted by activated B-
lymphocytes. Antibodies are Y-shaped molecules where the stem of the Y 
defines the class, or isotype, of the antibody. There are five different isotypes 
found in different compartments of the body where each of them has distinct 
effector mechanisms for disposing the recognized antigen.  Immunoglobulin A 
(IgA) dominates in secretions, while IgG is dominant in the blood and 
extracellular fluids. Although IgA is a relatively small component of the serum 
antibodies, the high abundance of IgA-secreting cells in mucosae makes IgA 
one of the most prevalent antibodies as they constitute 70% of all 
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immunoglobulins produced in mammals (Macpherson et al. 2008). 
Immunoglobulin G opsonizes pathogens for engulfment by phagocytes and 
activates the complement system, while IgA works mainly as a neutralizing 
antibody. While IgM is the first antibody to be produced in the humoral 
immune response process, these early antibodies have low affinity for their 
corresponding antigens. However, the IgM molecules can form pentamers that 
makes them able to bind simultaneously to multivalent antigens, compensating 
for the low affinity. This pentameric structure makes them especially effective 
in activating the complement system. Because of the large size of the 
pentamers, IgM is found mainly in the blood, while the other isomers are 
smaller and diffuse easily out of the blood into the tissues. Immunoglobulin E 
antibodies are present in very low concentrations in blood and extracellular 
fluid, they are bound to mast cells beneath the skin and mucosa and in the 
connective tissue along the blood vessels. Antigen-binding to IgE triggers mast 
cells to release chemical mediators that induce allergic reactions. 
Immunoglobulin D is the less abundant antibody, its function is unknown. 
(Janeway et al. 2005) 
3.2.1 Immunoglobulins in growing dogs 
Dogs have an endotheliochorial placenta, which constitutes a relatively 
impermeable barrier between the maternal and fetal circulation. Puppies are 
therefore born hypo-gammaglobulinemic and they receive passive immunity 
from the mother by antibodies transferred through colostrum.  Only a small 
amount of IgG is transferred over the placenta. The variation in the efficiency 
of uptake of colostral immunoglobulin may be related to the size and strength 
of the newborn puppy and the maternal abilities of the bitch, as well as the 
concentration of specific antibodies in the colostrum of the individual bitch 
(Mila et al. 2015).  
The serum levels of immunoglobulins increase during first year of life and 
reaches adult levels at one year of age (Schreiber et al. 1992). How the 
concentration of maternal immunoglobulins in serum and feces affects the 
immunoglobulin levels in their offspring is poorly studied in dogs. 
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3.3 The gastrointestinal immune system in dogs 
3.3.1 Mucosa 
The gastrointestinal tract is the largest immunologic organ in the body and the 
gut mucosa represents the primary point of contact between pathogens and the 
innate and adaptive immune response. In addition to acting as a physical and 
chemical barrier to mucosal pathogens, mucosal surfaces are highly active 
immunologically. Mucosal delivery of antigen has the potential to induce 
potent local and systemic immunity responses. The epithelial layer with 
intracellular tight junctions constitutes a physical barrier, preventing passage of 
pathogens. Other defence mechanisms in the gastrointestinal tract include low 
pH in the stomach, peristalsis, proteolytic enzymes and normal gut microbiota 
(Gelberg 2014).  
The gut-associated lymphoid tissue (GALT) is comprised of Peyer´s 
patches and diffuse lymphoid tissue. Peyer´s patches are located throughout the 
small intestine and have an important role in the production of IgA by plasma 
cells in the lamina propria (Hogenesch et al. 1992). Immunoglobulin A is the 
most abundant immunoglobulin in the body and has an important role in 
mucosal immunity by preventing the transfer of specific pathogens and their 
toxins across the intestinal epithelium. Microfold (M) cells (overlying the 
GALT), dendritic cells (DC) and the epithelial cells themselves are examples 
of antigen presenting cells (APC) in the gut epithelium that are responsible for 
the uptake of antigens in the gut (Knoop et al. 2013). 
3.3.2 Innate immune system 
The barrier function of intestinal epithelial cells is considered to be their most 
important contribution in preventing activation of the mucosal immune system 
by commensal bacteria and protein antigens (Shen et al. 2011). Intestinal 
epithelial cells possess many properties of cells of the innate immune system, 
in particular the ability to recognize and respond to pathogens. Antigen 
presenting cells recognize molecules on the pathogens called pathogen-
associated molecular patterns (PAMP), by pattern recognition receptors (PRR). 
Activation by microbes of a PRR called Toll-like receptor (TLR) in intestinal 
epithelium increases recruitment of B-cells to the lamina propria and results in 
increased secretion of IgA into the intestinal lumen (Shang et al. 2008). 
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3.4 The influence of environmental factors on the 
development of the immune system 
3.4.1 Epigenetics 
The term epigenetics was stated by Conrad Waddington (1957) to describe the 
process by which the inherited genotype could be influenced under 
development to produce a range of phenotypes. More recently the term has 
been defined as the molecular processes by which traits can persist across 
mitotic cell division without involving changes in the nucleotide sequence of 
the DNA (Bateson & Gluckman 2011).   
Environment plays a critical role during early life development and has 
ability to influence long-term health. Epigenetic programming during 
development, resulting in functional changes in gene expression, is thought to 
form underlying mechanisms in early-life programming. These epigenetic 
changes are likely to have great importance in contributing to phenotypic 
expression of complex disease and can be triggered by both environmental and 
genetic factors. Events or exposure during pregnancy can modify gene 
expression through epigenetic mechanisms, determining the functionality of 
the immune system (Haathela et al. 2013; Nauta et al. 2013).  
3.4.2 Microbial exposure 
The relation between early microbial exposure and development of the canine 
immune system is not well described. In humans, this area has evoked great 
interest in the research of allergy prevention and this text is therefore primary 
based on human research. 
The increase in allergy is paralleled with a reduced prevalence of infectious 
diseases (Aaby et al. 2009). The altered disease pattern is most likely 
associated with changes in environmental factors such as improvements in 
public health, disease treatment, vaccination programs and hygiene. Strachan 
proposed the so called hygiene hypothesis in 1989, explaining that the lack of 
microbial exposure as a result of hygienic conditions in early life may have an 
impact on the balance of the immune system, resulting in development of 
allergic diseases. In his study from 1989, Strachan suggests an association 
between the prevalence of hay fever/atopic dermatitis and the family size. He 
concluded that the higher infection rate of children with older siblings may 
have a protective effect upon allergic diseases.  The World Allergy 
Organisation (WAO) Special Committee on Climate Change and Biodiversity 
has stated an extension of the hygiene hypothesis; the biodiversity hypothesis 
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where urbanization is proposed to lead to loss of biodiversity, dysbiosis, 
immune dysfunction and inflammatory disease (Haathela et al. 2013). One 
example of this is a study by Laatikanen et al. (2011) who showed that 
allergies were more common in Finnish children and adults than in their 
Russian counterparts during 1997-2007. Furthermore, immigrant studies have 
shown that when immigrants move from non-affluent areas of low prevalence 
of disease to affluent areas of high prevalence of disease, their good health 
status declines and converges to that of the natives, indicating that tolerance 
mechanisms can rapidly become impaired in microbe-poor environments 
(Haathela et al. 2013).  
Several studies have shown association between microbial exposure and 
protection against allergy and asthma. Children growing up in farming 
environment had reduced risk of asthma and wheezing, prenatal exposure to 
such environments had the same effects (Braun-fahrländer et al. 1999; von 
Ehrenstein et al. 2000; Kilpeläinen et al. 2000; Portengen et al. 2002; Downs et 
al. 2001; Riedler et al. 2001; Douwes et al. 2007; Valkonen et al. 2015). 
Björkstén et al. (2001) found that infants who will develop allergy have a 
different composition of their gut flora compared to healthy infants, even 
before the development of any clinical manifestations of atopy. Furthermore, 
children treated with broad-spectrum antibiotics during early life have been 
shown to have an increased risk of allergic disease. Early exposure to 
antibiotics results in the decrease of microbial stimulation and subsequent 
reduction of the Th1-response. In addition, the disruption of intestinal 
microflora by antibiotics suppresses the Treg- response and thereby an 
upregulation the Th2-response (Kuo et al. 2013). Studies in germ-free mice 
have shown that exposure to commensal microbiota is critical for appropriate 
immune development (Sudo et al. 1997). The germ-free mice had significantly 
increased allergic airway inflammation and exhibited altered allergen-
presenting cell populations (Herbst et al. 2011). Tulic et al. (2000) showed that 
exposure to LPS could modify the development of allergic inflammation in 
sensitized rats.  
The importance of microbial exposure during the first moments of life is 
illustrated by findings that delivery mode may affect immunological function 
in infants. Under normal conditions of delivery there is transfer of fecal and 
vaginal bacteria from the mother to the baby.  It is shown that children born 
through sterile caesarean section have a different gut microbiota compared to 
vaginally born children (Grönlund et al. 1999; Huure et al. 2008; Azad et al. 
2013). These children may have increased risk of asthma and atopy –indicating 
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a disturbance in their immune function (Kero et al. 2002; van Nimwegen et al. 
2011).  
Microbial exposure activates pattern-recognition receptors, leading to 
downstream suppression of Th2-cell expansion and therefore Th2-mediated 
diseases such as allergies (Loss et al. 2012). Altered immunoregulatory 
mechanisms may also be important in this process; increased numbers of Treg 
cells have been found in newborn exposed to farming in utero (Schaub et al. 
2009). 
The hygiene hypothesis is challenged by increased prevalence of Th1-
autoimmune diseases and that Th2-skewed parasitic worm infections are not 
associated with allergy. So allergy development is not only a balance of 
Th1/Th2 responses, and Treg may potentially play a substantial role in the 
regulation of this process (Bauer et al. 2007). 
3.5 Gut microbiota in growing dogs 
Microbes are present throughout the entire gastrointestinal tract but their 
concentration is highest in the colon. Despite the simple gut of dogs, the canine 
gut microbiome is highly diverse with several hundred phylotypes represented 
(Handl et al. 2011; Swanson et al. 2011). Every individual dog has a unique 
and stable microbial ecosystem. All dogs have similar bacterial groups on a 
higher phylogenetic level, but the microbiome differs substantially on a 
species/strain level between each individual dog (Simpson et al. 2002) and 
genetically related dogs have a more similar fecal microflora than unrelated 
dogs (Hand et al. 2013). Most of the information about the gut microbiota in 
dogs is from mature dogs, only a few studies have investigated age-related 
changes in the microbiota and they showed dramatic changes in quantitative 
and qualitative characteristics of the microflora during postnatal development 
(Matsumoto et al. 1976; Benno et al. 1992). The sterile gastrointestinal tract of 
neonates is rapidly colonized by bacteria in the birth canal and the surrounding 
environment. Buddington (2003) showed that already 24 hours after birth, the 
numbers of bacteria in the GI-tract were comparable to those in adult dogs. 
After the numbers of bacteria have stabilized, further age-related changes 
involve changed relative proportions of the various groups of bacteria in the 
gut microflora, with an increase of anaerobic bacteria.  
In humans (Jost et al. 2014) and mice (Perez et al. 2007) it has been shown 
that during lactation, intestinally derived bacterial components were 
transported within cells of the intestinal lymphoid tissue to the mammary 
glands through the lymphatic system and peripheral blood. This transfer of 
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maternal microbiota to the newborn via milk was suggested to program the 
neonatal immune system to recognize specific bacterial molecular patterns and 
to respond appropriately to pathogens and commensal organisms.  
3.6 Probiotics 
3.6.1 Safety 
Probiotics are defined as living microorganisms, which when administered in 
adequate amounts confer health benefits on the host (FAO/WHO 2002). 
Bacteria used as probiotics should have ability to express their activities in the 
host.  Commercial probiotic preparations are mainly based on lactic acid 
bacteria (Lactobacillus, Bifidobacterium and Enterococcus) -important 
components of the gastrointestinal microflora and relatively harmless 
(Ishibashi et al. 2001). Since probiotics are considered to be food supplements, 
not drugs, they are not regulated with respect to efficacy and quality, and few 
studies have been conducted examining the safety of probiotic supplementation 
in dogs (Weese 2003). One of these studies investigated the safety and 
tolerance of dietary supplementation with the probiotic Bifidobacterium 
animalis AHC7 fed to growing dogs demonstrated that 5 x1010 CFU once per 
day for at least 12 weeks was well tolerated by growing dogs with no safety 
concerns (Kelley et al. 2010). 
The discovery of probiotic bacteria in human infection sites has evoked 
debate in recent years over the safety of probiotics (Adams et al. 1995). 
However, cases of infection due to the commonly used probiotics are 
extremely rare in humans and most of the cases occur in patients with severe 
underlying conditions (Cannon et al. 2005). 
Another issue regarding probiotic safety is antibiotic resistance. This is not 
a hazard unless it makes the probiotic untreatable in cases where it has caused 
infection or unless the resistance can be transferred to potential pathogens. 
Resistance plasmids with antibiotic-resistance genes including genes encoding 
resistance to tetracycline, gentamicin, chloramphenicol, and macrolide-
lincosamide-streptogamin have been found in L. reuteri, L. fermentum, L. 
acidophilus and L. plantarum (Gevers et al. 2003). 
3.6.2 Proposed immunologic mechanisms of probiotics 
It is well documented that probiotics have immunomodulatory effects upon its 
host, influencing both the innate and adaptive immune systems. The health 
benefits of probiotics are strain specific and there is no universal strain that 
provide all proposed benefits (Morita et al. 2002). Intestinal epithelial cells and 
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dendritic cells (DC) interact extensively with probiotics. These cells respond to 
the gut microbiota through their pathogen recognition receptors (PRRs). Toll-
like receptor (TLR) signaling is essential in mediating the anti-inflammatory 
effects of probiotics (Rachmilewitz et al. 2004). Probiotic microorganisms 
activate the DCs via TLR, and DC initiates the appropriate response as 
differentiation of Th0 to Treg (Hart et al. 2004; Di Giacinto et al. 2005).  
Probiotic organisms can modulate gastrointestinal permeability and 
enhance epithelial barrier function in vitro and in whole animal models. 
Intestinal barrier defence consists of the mucous layer, antimicrobial peptides, 
secretory IgA, and the epithelial junction adhesion complex. Mucins are 
constituents of epithelial mucus. Probiotics may promote mucous secretion and 
enhance mucin expression in vivo and in vitro (Caballero-Franco et al. 2007), 
improving the barrier function and the exclusion of pathogens.  
Mazmanian et al. (2005) studied the effect of the symbiotic Bacteroides 
fragilis on the immune maturation in germfree mice and showed that 
maturation of the mammalian immune system requires direction of an 
immunomodulatory molecule provided by symbiotic bacteria. The bacteria 
contains an immunomodulatory molecule that directed the development of 
CD4+ T cells and elicited appropriate cytokine production which may correct 
the immunologic defects found in the absence of bacterial colonization. 
Administration o Lactobacillus reuteri CRL-1098 to vitamin B12 deficient 
mice during pregnancy and lactation, prevented serum vitamin B12 deficiency 
and increased IgA producing cells within the small intestine (Molina et al. 
2009). In another mouse study (De Moreno de LeBlanc et al. 2008), 
administration of Lactobacillus casei DN-114001 during lactation resulted in 
increased secretory IgA in the intestinal fluid, and decreased macrophages, 
dendritic cells and IgA+ cells in the offspring. The mothers that received 
probiotics during lactation had higher levels of secretory IgA in their milk. The 
increase in secretory IgA in the offspring during the suckling period was 
therefore suggested to be transferred through lactation. Kaburagi et al. (2007) 
showed that administration of Lactobacillus johnsonii La1 enhanced intestinal 
IgA production and helped recovery from malnutrition-related immune 
problems in aged mice.  
Increased levels of fecal IgA have also been shown in healthy adult humans 
after three weeks treatment with Bifidobaterium lactis (Kabeerdoss et al. 
2011). 
Defensins are antimicrobial peptides, active against bacteria, fungi and 
viruses. Specific probiotic strains including lactobacilli upregulate the 
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expression of defensins and thus impact on the antibacterial activity of the gut 
(Schlee et al. 2008). 
The cytokine-secretion from intestinal epithelial cells is induced by 
probiotics in a strain-specific manner. Morita et al. (2002) studied eleven 
strains of lactobacilli for their ability to induce the murine macrophage-like cell 
line J774 to secrete cytokines. Some of the bacteria induced the production of 
IL-6, IL-12 and TNF-α, the majority of the strains also induced secretion of IL-
10. Rangavajhyala et al. (1997) showed that L.acidophilus stimulated murine 
macrophages and induced the production of IL-1a and TNF-a, which co-
stimulate the activation of T-helper cells. In an in vitro study by Kainulainen et 
al. (2015), canine Lactobacillus acidophilus LAB20 decreased LPS-stimulated 
IL-8 production and strengthened the epithelial barrier function by increasing 
transepithelial electrical resistance (TER). 
3.6.3 Probiotics in clinical trials with dogs as study object 
The effect of probiotic supplementation on canine microbiota, as well as its 
survival in the gastrointestinal tract, has been studied. It has been shown that 
different strains of probiotics survive transit through the canine gastrointestinal 
tract and temporary, but not permanent, influence the composition of the 
microflora in the adult healthy dog (Baillon et al. 2004; Manninen et al. 2006; 
Biagi et al. 2007; Garcia-Mazcorro et al. 2011; Strompfová et al. 2014).  
The majority of the clinical trials where probiotics are tested in dogs, are 
focused on the treatment of diarrhea. Probiotic treatment has been shown to 
reduce the convalescence time in acute gastroenteritis (Kelley et al. 2009; 
Herstad et al. 2010). In dogs with non-specific dietary sensitivity, probiotic 
treatment improved fecal consistency, fecal dry matter and defecation 
frequency (Pascher et al. 2008). Sauter et al. (2006) studied the effects of 
probiotic supplementation in dogs with food responsive diarrhea, all dogs 
clinically improved after treatment. Treatment with symbiotic bacteria reduced 
the prevalence of diarrhea during periods of stress in healthy dogs (Gagné et al. 
2013). 
The immune stimulatory effect of probiotic supplementation is not well 
studied in dogs and a positive effect has mainly been in puppies. Benyacoub et 
al. (2003) studied the immune stimulatory effects of Enterococcus faecium 
(SF68) when supplemented to beagles from weaning to one year of age. The 
probiotic treatment increased fecal IgA and canine distemper virus (CDV) 
vaccine-specific circulating IgG and IgA.  However, this probiotic strain 
(SF68) was also used in a study by Simpson et al. (2009) who supplemented it 
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to adult dogs with chronic Giardiosis for sex weeks. They could not find any 
effect on fecal IgA concentrations or circulating leukocyte phagocytic activity. 
Chung et al. (2009) showed that 7 weeks treatment with recombinant 
Lactobacillus casei to beagle puppies, starting at 7 weeks of age, increased 
monocytes in blood as well as serum IgA, and enhanced vaccine response. 
Baillon et al. (2004) treated 15 adult dogs with Lactobacillus acidophilus for 2 
weeks; this treatment increased the concentration of neutrophils, monocytes, 
and serum IgG. 
The immunological mechanisms of probiotics have made their use 
interesting in the prevention and treatment of immune-related diseases, such as 
allergies. There are few studies focusing on probiotic treatment in the 
prevention of canine atopic dermatitis (CAD) and these are based on laboratory 
dogs. In a study by Marsella (2009), 2 beagles with severe atopic dermatitis 
were bred twice. The puppies in the second litter received Lactobacillus 
rhamnosus GG between 3 weeks and 6 months and the mother was treated 
during pregnancy and lactation. Both litters were sensitized to 
Dermatophagoides farinae. The litter treated with probiotics had significantly 
lower serum titer of allergen-specific IgE and milder reaction to intradermal 
testing compared to the first litter, but the treatment had no effect on clinical 
signs. In a follow-up study (Marsella et al. 2012) 3 years after discontinuation 
of the probiotic treatment, the atopic dogs treated with probiotics early in life 
had decreased severity of clinical signs and lower production of IL-10 in 
PBMCs compared to the placebo-group. These results indicate a long-term 
effect of early probiotic treatment upon clinical signs of CAD. The effect of 
Lactobacillus sakei probio-65 upon clinical signs of CAD was studied in a 
placebo-controlled trial where 42 dogs with CAD were included, 32 of the 
dogs were treated with the probiotics for two months.  The treatment resulted 




4 Material and methods 
This section outlines overall issues regarding the material and methods used in 
the separate papers in this thesis. For detailed descriptions, the reader is 
referred to each individual paper. 
4.1 Study populations 
Two populations were studied in this thesis; German Shepherd dogs insured in 
the Swedish insurance company Agria (paper I), and German Shepherd dogs 
born and raised at the Swedish Armed Forces kennel (paper II-III). 
4.1.1 Insured population (I) 
A large proportion of the Swedish dog population is covered by an insurance 
plan. About one-third of the Swedish purebred dog population is insured by the 
insurance company Agria. This company offers insurance that covers the costs 
for veterinary care as well as life insurance for pets (Egenvall et al. 1998). 
Most dogs insured for veterinary care also have a life insurance policy. The 
Agria database has been validated as a useful tool for epidemiological research 
of overall morbidity and mortality, as well as specific diseases in dogs (Bonnett 
et al. 1997).  
The study population consisted of 445,336 dogs enrolled in both veterinary 
care and life insurance before 12 months of age between 1995 and 2006 in 
Agria, 32,486 (7.3 per cent) of these were GSDs. 
The insurance database used for this study was developed to register claims, 
and it cannot be considered a perfect source of information on the disease 
prevalence. However, the number of dogs in the database is large, and high 
statistical power can be achieved, making it well suited to describe the 
occurrence of disease and death within a breed and differences across breeds. 
In paper I, only the first veterinary claim for each animal has been included, 
which is most appropriate for examining and comparing risk across breeds, but 
underestimates the entire burden of disease, in that, individual dogs with 
chronic conditions might have many veterinary visits over the course of their 
lives. So, given that these are data from one country, and there are limitations 
of the insurance database, exact rates and risks should be extrapolated 
cautiously.  
4.1.2 Swedish Armed Forces kennel (II-III) 
Paper II and III are based on a large clinical trial where the study population 
consisted of GSD litters from the Swedish Armed Forces (SAF) kennel in 
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Sollefteå, Sweden, which breeds GSD for service duties. This well controlled 
population of dogs which are bred in special facilities constitutes an ideal 
population for research aims. The majority of the bitches used in the breeding 
were imported or internally recruited from the kennel. The bitches lived with 
their families and arrived at the kennel at pregnancy day 37 or earlier. All 
bitches and their litters were housed and treated with the same routines at the 
kennel. When the puppies were 8 weeks old, they were moved from the kennel 
to live with families throughout Sweden. The families wrote a diary during the 
observation period where signs of disease, fecal score, body condition score, 
changes in environment etc. were noted. Mothers and puppies were restricted 
to the same diet during the entire study period. Mothers and their litters were 
separated from other dogs at the kennel and they were not exposed to other 
food.  
Paper II included 15 litters (the placebo group in paper III) while paper III 
included 30 litters.   
4.2 Study designs 
In paper I we performed a retrospective longitudinal cohort study in order to 
describe the disease patterns for morbidity and mortality in GSDs in Sweden, 
based on insurance data from the years 1995–2006. This included 
determination of the most common disorders within the breed, as well as a 
comparison with other breeds in order to identify disorders where the GSD is 
relatively over-represented. We also tested the hypothesis that GSDs are 
predisposed to immune-related disorders. 
To establish well defined data for comparison in further studies on the 
effect of relatedness as well as interventions in the environment, in paper II we 
performed a prospective study where we followed changes in serum and fecal 
IgA and serum IgE from birth to young adult age in entire litters and their 
dams. We also tested if dogs with lower serum IgA have low fecal IgA and/or 
serum immunoglobulin IgE. To reveal if any of the parameters could be proven 
to influence the immune response, we further measured serum IgG response to 
vaccination against canine distemper virus (CDV). 
Paper III was based on a double-blinded placebo-controlled retrospective 
trial where the aim was to explore the development of the gut microbiome in 
GSD from puppy to adulthood and furthermore, to study the relation to 
maternal microbiome composition and living environment in a large and well-
defined population of dogs. Additionally, we evaluated whether administration 
of probiotics (Lactobacillus johnsonii NCC533, La1) would enhance IgG 
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antibody responses against CDV in serum, and assessed the effects on the fecal 
microbiome of early age probiotic supplementation to bitches and puppies.  
In this paper, the pregnant bitches were divided into two equally sized 
groups through block randomization (block size 6), where one group received 
probiotic supplementation (Lactobacillus johnsonii NCC533, La1) and the 
other group placebo (maltodextrin). The bitches started on treatment three 
weeks prior to estimated parturition (pregnancy day 42), and continued until 
the puppies where eight weeks old. Puppies received oral treatment (same as 
their mother) at the age of 3 weeks at the onset of exposure to solid food. The 
treatment continued until the puppies were 12 weeks old (Figure 2).  
 
Figure 2. Flow diagram showing time for sampling, treatment and observation 
period. 
 
4.3 Sampling (II-III) 
Blood and feces were collected from bitches at pregnancy day 42, 12-24h after 
completed whelping, 4 and 7 weeks postpartum. Blood and feces were 
collected from puppies at 7 weeks, 12-13 months (median 12 months and 20 
days) and 15-18 months (median 16 months and 16 days) of age (Figure 2). 
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4.3.1 Blood samples 
Blood samples were collected from the cephalic vein. Before centrifugation, 
samples were left to clot for at least 30 min in room temperature. After 
centrifugation (10 min, 7200 rpm), serum was collected and frozen. All 
samples were frozen at -80°C within 48 hours. Between collection and freezing 
at -80°C, the samples were stored in dry ice or in -25°C freezer. 
4.3.2 Fecal samples 
Fecal samples used for the 454 pyrosequencing (paper III) were collected by 
rectal swabs. Fecal IgA was extracted from 0.5g of fresh (mothers) or frozen 
(puppies) feces, collected in relation to defecation. The frozen fecal samples 
were frozen within two hours of collection and extracted in association with 
analysis, while the fresh fecal samples were extracted within 45 min and then 
frozen. All fecal samples were frozen at -80°C within 48 hours. Between 
collection and freezing at -80°C, the samples were stored in dry ice or in -25°C 
freezer. 
4.4 Laboratory analyses (II-III) 
All laboratory analyses were performed at Nestlé Purina Research Facilities in 
St. Louis, Missouri, USA. 
4.4.1 Immunoglobulins in serum and feces 
Serum and fecal extracts were assayed for fecal IgA, serum IgA, total serum 
IgE (Bethyl laboratories, Inc.), and IgG against CDV (VMRD) within 45 
months by ELISA (Bethyl laboratories, Inc.). The concentration of fecal IgA 
was adjusted against total protein content in feces and expressed as µg IgA/µg 
total protein (TP). The concentration of serum immunoglobulins were 
expressed as g/L. 
4.4.2 Assessment of fecal microbiome 
The fecal microbiome was assessed by 454-pyrosequencing in all samples 
from puppies (three samples per puppy) and from bitches at pregnancy day 42, 
partum and 7 weeks postpartum.  
Fecal genomic DNA was extracted using Qiagen genomic DNA extraction kit 
(Uppsala, Sweden) following manufacturer’s protocol. 16S rRNA gene 
pyrosequencing was performed at the Core for Applied Genomics and 
Ecology, University of Nebraska, Lincoln. All samples were multiplexed with 
equal amount and sequenced using Roche GS FLX pyrosequencer. The raw 
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data from 454-pyrosequencing were processed using QIIME version 1.8.0 
(Caporaso et al. 2010). Data were filtered to remove low-quality reads not 
meeting the quality criteria. Sequencing errors characteristic to pyrosequencing 
were removed by flowgram clustering (Reeder et al. 2010). Chimeric 
sequences generated due to PCR amplification of multiple sequences were 
removed using UCHIME (Edgar 2010). Processed reads were then 
demultiplexed into barcode-indexed samples. The barcode, forward primer, 
and reverse primer were subsequently trimmed from each read. This yielded a 
total of 1502990 reads from 507 samples from puppies and 246464 reads from 
90 samples from bitches. The average length of the reads was 427 and 338 bps 
for bitches and puppies respectively. 
Reads were clustered into operational taxonomic units (OTU) using a 
closed reference-based UCLUST algorithm at a 97% sequence similarity level 
implemented in QIIME (Edgar et al. 2010). The reference sequences and 
taxonomy assignment map were constructed from the greengenes database 
[www.greengenes.lbl.gov].  
4.5 Statistical analyses 
In paper I the morbidity in GSDs insured in Agria was calculated as true 
incidence rates (IR) where the denominator was the sum of each animal’s total 
time in the register and number of disease events, where only the first claim for 
each dog within each general or specific category was included, was the 
numerator. The IR were multiplied by 10,000 and presented as number of 
events per 10,000 dog years at risk (DYAR). The mortality in GSDs insured in 
Agria was calculated as mortality rates (MR) where the number of deaths was 
divided by the sum of each animal’s total time in the register. Mortality rates 
were multiplied by 10,000 to be interpreted as the number of deaths per 10,000 
DYAR. Both MR and IR in GSDs were compared with those for all other 
breeds (combined) and presented as relative risk (RR). Standard error 
multiplied by 1.96 yielded 95% CI for IR, MR and mean ages and GSDs were 
considered to have a significant difference for the comparison for conditions 
where the CIs did not overlap those for all other breeds. Significant differences 
in the proportion of males and females within conditions (diagnoses) were 
detected using Proc Freq and the exact two-sided binomial test (SAS). The 
analysis was done using the software package SAS V.9.3 (SAS Institute, Cary, 
North Carolina, USA). 
In paper II, R (R Core Team, 2012) and lme4 (Bates et al. 2012) were used 
to perform linear mixed effect analyses of 1) the relationships between Ig-
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concentrations in mother and offspring, 2) the relationships between the 
different immunoglobulins, 3) the change of immunoglobulins over time, 4) 
the impact of sex on immunoglobulins, and 5) the impact of litter size on 
immunoglobulins. The results were presented as the estimated population mean 
differences based on the model (β).  
Intra Class Coefficients (ICC) was used to quantify the degree to which 
individuals with a fixed degree of relatedness resemble each other in terms of a 
quantitative trait (immunoglobulin concentrations).  
In paper III, the relationships between the microbiome and metadata 
variables were explored using Orthogonal partial least square method with 
discriminant analysis (OPLS-DA) (Trygg et al. 2002; Ramdan et al. 2014) 
using SIMCA-P+ and MATLAB routines. In OPLS-DA models the cross-
validation parameter, Q2 (which can range from -1 to +1), is reported. Analysis 
of variance testing of cross-validated predictive residuals (CV-ANOVA) was 
also applied for each model. Principal components analysis (PCA) and 
pairwise OPLS-DA were applied to sample clusters (age, treatment, living 
area) with unit-variance scaling.  
Shannon index was calculated for each rarefied OTU table. Mann Whitney 
U test was performed to compare the difference in diversity indexes between 
groups and the P values and mean +/- SD were reported. The OTU table was 
normalized by the total sum for each sample and was expressed as relative 
abundance. Linear discriminant analysis (LDA) effect size (LEfSe) was 
utilized to identify differentially abundant bacterial taxa.  
In order to study if littermates had a more similar composition of the fecal 
microbiome than unrelated dogs of same age, an analysis of similarity 
(ANOSIM) was performed, where a p-value of <0.05 was regarded as a 
significant difference between litters (litter effect). 
R (R Core Team, 2012) and lme4 (Bates et al. 2012) were used to perform 
linear mixed effect analyses on the change of immunoglobulins over time and 
the effect of probiotic treatment upon immunoglobulins.  
4.6 Ethical considerations 
The study was approved by the Local Animal Ethical Committee in Uppsala, 
Sweden (C355/9). 
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5. Results and discussion
5.1 The German Shepherd dog is predisposed to 
immune-related disorders (I) 
In paper I we showed that German Shepherd dogs were over-represented for 
immune-related disorders, it was 2.7 times more common that a GSD had 
immune-related disorders compared with other breeds (Figure 3). Our result is 
in agreement with other epidemiological studies and case studies showing a 
predisposition for many of these disorders in GSDs (Wisselink et al. 1985; Day 
et al. 1986; Batt et al. 1991; Clark et al. 2005; Nødtvedt et al. 2006). This 
predisposition is suggested to be a result of inherited defects in the immune 
system (Whitbread et al. 1984; Day and Penhale 1988; Batt et al. 1991; Griot-
Wenk et al. 1999). A predisposition for low serum IgA levels have earlier been 
reported in GSDs (Whitbread et al. 1984). 
Figure 3. Relative Risk (RR) for general causes of veterinary care in the 
German Shepherd dog compared with allother breeds. Disease categories with 
a significant difference (non-overlapping CI intervals) between IRs in GSDs 
and all other breeds have red bars. 
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In paper I, we used a standardised diagnostic registry (Swedish Animal 
Hospital Organisation 1993), including both specific and general codes in 
hierarchical order. In general, only one diagnostic code was used per claim. 
The original diagnosis (provided by the veterinarian) was then collated into 
specific and then more general categories of diagnoses. The 24 general disease 
categories were based on body system or disease process. The general disease 
category ‘immunological’ was divided into three major groups; ‘allergic’, 
‘autoimmune’ and ‘various immune-related diseases’ (Table 1). Of these three 
groups, allergic diseases were the most common among GSDs and this group 
also had the highest RR regarding morbidity, GSDs were 3.1 times more likely 
to have at least one veterinary care event for allergic disease compared with 
other breeds. Allergic disease was also the group of immune-related disorders 
where the mortality rate in GSDs was highest. It was 6.3 times more common 
that a GSD died/was euthanized due to allergic disease, when compared with 
all other breeds. ‘Atopy’ was the specific diagnosis with the highest RR, being 
3.6 times more common than in other breeds, regarding mortality it was the 
seventh most common specific cause of death and the RR was 7.3 compared 
with all other breeds. The recorded diagnosis of atopy in the insurance database 
has been validated against practice records and the agreement was considered 
acceptable (Nødtvedt et al. 2006). Recently, genome wide analysis in GSDs 
reveals associations of a locus on CFA27 with atopic dermatitis and haplotype 
association analysis from the fine mapping data indicated association to the 
gene, plakophilin 2 (PKP2), known to be important for skin structure. Low(er) 
IgA levels were, in that study, correlated to increased risk for atopy (Tengvall 
et al. 2013).  
Including some diagnoses that are suspected to be immune-related, but not 
included in the category ‘immunological’, there are some breed-specific 
diseases, such as ‘German shepherd dog pyoderma’ ‘exocrine pancreatic 
insufficiency’ (EPI) and ´circumanal fistulae’. Not surprisingly, the GSD 
pyoderma was a diagnosis seen almost exclusively in GSDs. Exocrine 
pancreatic insufficiency, or the more specific diagnosis exocrine pancreas 
atrophy, is a disease mainly seen in a few breeds, including GSD which had a 
strong predisposition to this diagnosis in our study both regarding mortality 
and morbidity. ‘Circumanal fistulae’ was the specific skin diagnosis with the 
highest mortality rate, as well as the highest RR of mortality. It was 87.9 times 
more common that ‘circumanal fistulae’ was the cause of death in GSDs 
compared with all other breeds. . ´Circumanal fistulae’ was also the specific 
skin diagnosis with highest RR regarding morbidity, this diagnosis had 46 
times higher incidence rate in GSDs compared with all other breeds. This is a 
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disorder with a proposed immune-related aetiology (Day and Weaver 1992) 
with high breed predisposition in GSD (Massey et al. 2014).  
The most common general disease category in GSDs was skin disorders, 
this category had almost twice the risk compared with all other breeds. 
‘Itching’ was the most common specific diagnosis within the general category 
‘skin’. Many of the dogs in the ‘itching’ group were also represented in the 
group of allergic diagnoses indicating that the allergic dog was diagnosed with 
‘itching’ before an investigation for allergic disease was completed. Although 
skin problems are common morbidities among dogs in general, the GSD stands 
out as a breed in which the problems are severe enough to result in euthanasia.  
‘Skin’ is the general category where the GSD was most over-represented with 
a RR of mortality at 7.8 compared with other breeds.  
Dogs with a condition that presents a challenging diagnostic problem are 
likely to be hidden within various diagnostic codes, this would result in an 
underestimation if only the rate based solely on the specific diagnosis was 
examined. Also, a dog may be given multiple different diagnoses over the 
course of a chronic problem, and show up in different categories. In order to 
handle these diagnostic considerations described, we used hierarchical 
classifications and presented both general and specific diagnostic categories 
(Table 1). 
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Table 1. An example of the hierarchical classification of diagnoses used in 
study I.  
5.2 Immunoglobulins in the growing GSD (II) 
In this extensive study of long-term changes of different immunoglobulins in a 
well-defined population of 74 growing GSD we identified a positive 
relationship between fecal IgA and serum IgG against CDV at all ages that 
might have clinical implications. We also found that the levels of serum IgE, 
serum IgA and fecal IgA are significantly lower in puppies and that levels are 
stabilized after one year of age. At 7 weeks, fecal IgA levels ranged between 
0.010-0.175 µg IgA/µg TP, serum IgA ranged between 0.039-1.299 g/L and 
serum IgE between 0.0004-0.0242 g/L. At 12-13 months, fecal IgA levels 
ranged between 0.002-0.347 µg IgA/µg TP, to be compared with the maternal 
Level 3 Level 2 Level 1 Specific diagnosis Original diagnosis 
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levels (0.011-0.165 µg IgA/µg TP, 7w postpartum). Serum IgA levels at 12-13 
months ranged between 0.165-2.921 g/L, to be compared with the maternal 
levels between 0.534-0.845 g/L. At 12-13 months, serum IgE ranged from 
0.0005 to 0.0711 g/L, to be compared to the maternal levels (0.002-0.145 g/L). 
The finding of lower levels of serum IgE, serum IgA and fecal IgA in 
puppies that stabilizes after one year of age is in accordance with previous 
studies (Glickman et al. 1988; Schreiber et al. 1992; Racine et al. 1999; Zaine 
et al. 2011; Olsson et al. 2014). The variation increased by age which could be 
a result of increased exposure to varied environmental factors.  
Serum IgE and IgA were positively related to each other at 15-18 months. 
Fecal IgA and serum IgA was not related to each other. 
There was no relationship between the mother and her puppies at seven 
weeks regarding serum IgE, serum IgA, or fecal IgA. The correlation within 
litters (intra class coefficients, ICC) for fecal IgA and serum IgG against CDV 
decreased with age, while serum IgA increased by age. In serum IgE, the ICC 
was close to 0 at all time-points. 
We measured CDV vaccine response as a marker for the systemic immune 
status. Vaccine responses demonstrate clinically relevant alternations in an 
immune response to a challenge under well-controlled conditions and therefore 
are often used as a surrogate for responses to an infectious challenge. Fecal 
IgA was positively related to vaccine response at all ages, which means that 
dogs with high fecal IgA have a better vaccine response also indicating a 
favorable systemic immune status. Satyaraj et al. (2013) showed that colostrum 
supplementation increased fecal IgA as well as vaccine response, but it is 
unknown if the increased vaccine response resulted from the increase in fecal 
IgA. 
Griot-Wenk et al. (1999) showed a negative correlation between serum IgE 
and serum IgA and the authors suggested that increased IgE levels might 
represent an important immune response to reduced IgA levels. We could only 
find a relationship between these immunoglobulins at 15-18 months (positive) 
and not in the other age groups which is in accordance with a study by Hill et 
al. (1995) where they did not find any correlations between serum IgA, IgE and 
IgG in a population of adult dogs. 
How the concentration of maternal immunoglobulins in serum and feces 
affects the immunoglobulin levels in their offspring is not well studied in dogs. 
We could not find any relationship in immunoglobulin concentrations between 
bitches and their puppies when the puppies were seven weeks old. The puppies 
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however strongly resembled each other in fecal IgA, indicating that even if 
there is no relationship between mother and puppies, there is a strong relation 
between litter mates.  This could be a result of an oral transfer through 
ingestion of each other´s feces within the litters. The ICC for IgG against CDV 
was high in the 7 weeks old puppies, but decreased when the dogs were older. 
Since the puppies were unvaccinated at sample collection at 7 weeks of age, 
IgG are supposed to have maternal origin and the transfer through colostrum 
should be equal within the litter. However, when the dogs are older, there 
might be environmental factors that affect the results and the increased 
variation might influence the ICC. 
From 8 weeks of age, puppies lived with families which resulted in an 
increase in the variation arising from environmental factors. These results 
would be more applicable to pet dogs living in the society as compared to data 
from laboratory dogs and of great value when comparing immunoglobulins 
levels studies on immune stimulation in natural populations of growing dogs. 
5.3 The fecal microbiome in the growing GSD (III) 
The third paper included 30 bitches and their 168 offspring. The composition 
of the microbiota in puppies showed a clear age-related structure with a 
significant difference between 7 weeks old puppies and dogs at 15-18 months 
of age (OPLA-DA; Q2=0.61) (Figure 4). Firmicutes was the most dominant 
phylum at all ages with a relative abundance of 78–89%. Actinobacteria was 
the second most dominant phylum at all ages with a relative abundance of 4-
9%. At 7 weeks of age, Bacteroidetes was the third most dominant phylum 
with a relative abundance of 7%, whereas at 12-13 months and 15-18 months 
of age, Fusobacteria were the third most dominant phyla (4%). Earlier studies 
have described a similar pattern in adult dogs using pyrosequencing of fecal 
samples (Middelbos et al. 2010; Handl et al. 2011; Garcia-Mazcorro et al. 
2012). Although the predominant phyla are similar, proportions vary among 
these studies. Several sources can contribute to such variability, including 
breed, age, living conditions, diet and methodology. The maturation of 
microbiota by age was restricted to the composition of the fecal microbiome 
and was not reflected in the microbial alpha diversity. 
There was a strong litter effect at 7 weeks of age when the puppies lived in 
the same environment (ANOSIM analysis on weighted UniFrac distances: 
R=0.49, p=0.001). This litter effect was less obvious, but still significant, at 18 
months of age (weighted UniFrac R=0.17, p=0.001).  This could be explained 
by a more heterogenic environment at 13 and 18 months of age, compared to 7 
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weeks where the puppies lived in the same place. Our results are in accordance 
with the results of Hand et al. (2013) who showed that 11 closely related 
miniature Schnauzer dogs had a more similar fecal microbiome profile 
compared to unrelated dogs within the same breed. By contrast, Middelbos et 
al. (2010) could not find any correlation in a study where they compared 3 
pairs of littermates. However, our study compared a much larger number of 
litters (n=30) and this may account for the discrepancies between studies.  
There were more pronounced differences in the composition of the fecal 
microbiome among younger (7 weeks old) than older (>12 months) dogs. This 
could be explained by a greater variation in diet between litters at 7 weeks of 
age, were some of the litters were weaned and only had solid food, while 
others were still suckling. The composition of microbes and oligosaccharides 
in the milk may also have had an effect.   
5.4 The fecal microbiome in pregnant and lactating 
bitches (III) 
Firmicutes was the predominating phylum also in the bitches at all sampling 
points with relative abundances of 50-75%. The bacterial community structure 
in bitches was stable from pregnancy day 42 to partum, but was shifted after 
whelping (between partum and 7 weeks postpartum; OPLS-DA, Q2=0.64 and 
pregnancy day 42 to 7 weeks postpartum; OPLS-DA, Q2=0.57. Lactobacillus 
spp. was one of the species that increased during lactation, this species was 
also higher in relative abundance in 7 week old puppies compared to young 
adults (Figure 4). Canine milk contains lactobacilli and may be a natural 
source of these potentially probiotic bacteria for the suckling puppy (Martin et 
al. 2010). In humans (Donnet-Hughes et al. 2010; Jost et al. 2014) and mice 
(Perez et al. 2007) it was shown that during lactation, cells of the intestinal 
lymphoid tissue travelled to the mammary glands through the lymphatic 
system and peripheral blood, transferring maternal microbiota to the new-born 
via milk. This entero-mammary pathway could be a possible route in which 
maternal probiotic treatment during lactation affected the microbiota in 
suckling puppies. However, we could not detect a difference in the amount of 
lactobacilli in the fecal microbiome of puppies between the La1-group and the 
placebo group. 
The microbial alpha diversity increased from pregnancy day 42 to 7 weeks 
postpartum (Shannon´s diversity index: 3.76±0.41 to 4.03±0.37, p<0.01).  The 
diversity was higher in the mothers than in the puppies at all ages. 
Interestingly, the composition of the microbiota also differed between the 
mothers 7 weeks postpartum and the 15-18 months old dogs (Q2=0.84). The 
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composition of the fecal microbiota in bitches was more similar to the 
microbiota of puppies at 7 weeks postpartum than at partum. The 7 weeks old 
puppies were no more similar to the mothers than to unrelated bitches at 
partum. However, the puppies were significantly more similar to their mothers 
than to unrelated bitches at 7 weeks postpartum.  
It was no difference in composition of the fecal microbiome between 
mothers and unrelated bitches at partum when comparing with 7 week old 
puppies. Our findings are similar with what Koren et al. (2012) found in 
humans where they showed that children´s microbiomes (at all ages) were no 
more similar to their own mothers´ than unrelated mothers´. However, the 
puppies were significantly more similar to their mothers than to unrelated 
bitches at 7weeks postpartum. This could be explained by the mothers´ 
behaviour of eating their puppies stool, making the maternal microbiome more 
similar to the microbiome of their puppies. That could also explain why the 
relative abundance of Lactobacillus spp. increased in the bitches during 
lactation.   
As far as we know, this is the first study so far comparing the gut 
microbiome in pregnant and lactating bitches. Koren et al. (2012) showed that 
the composition of the gut microbiome in women changes dramatically during 
pregnancy but are then stabilized during first month postpartum. This finding 
was supported by Carrothers et al. (2015), Hesla et al. (2014) and Jost et al. 
(2014) who found that the microbiome in lactating women was relatively stable 
in the postpartum period. The results from the human studies are in contrast to 
our study where we found a significant change in the bitches fecal microbiome 
during lactation, which –once again –could be explained by the canine 
mothers´ behaviour of eating their puppies stool.  
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Figure 4.  Relative abundance of bacteria family in feces from bitches at 
pregnancy day 42, partum and 7 weeks postpartum and from puppies at 
7weeks, 12-13months and 15-18months of age. Families with relative 
abundance >1% are included. 
5.5 The effect of environmental factors upon the fecal 
microbiome (III) 
The bitches were treated daily with Lactobacillus johnsonii NCC533( La1) 
from pregnancy day 42 until the puppies where 8 weeks old. Puppies were 
treated between 3-12 weeks of age. Supplementation of the probiotic strain 
(La1) did not influence the diversity or composition of the microbiome in 
either the bitches or the puppies. The probiotic treatment did not affect the 
levels of serum IgA, total serum IgE, or the fecal IgA in bitches or puppies. 
There were no differences between the microbiome in dogs with low fecal 
IgA-levels and those with high fecal IgA-levels.  
Alpha diversity was significantly affected by living environment 
(countryside, small cities or big cities). Dogs living in big cities had higher 
diversity compared to dogs living in small cities (3.36±0.63 vs 2.95±0.81, 
p<0.01) or at the countryside (3.36±0.63 vs 2.91±0.83, p<0.01). These 
differences were not observed at 7 weeks of age when all puppies shared the 
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same environment at the kennel, indicating that living area is the affecting 
factor in this aspect. Dicksved et al. (2007) showed that anthroposophically 
raised children had higher diversity of their fecal microbiome compared to 
farm children, indicating that living conditions affect the diversity of human 
fecal microbiome. It was, however, not possible to pinpoint the responsible 
factors in their lifestyle that contributed to this difference. One important factor 
could be the diet, since the different lifestyles are related to consumption of 
different food. In our study, food was standardized throughout the whole study 
period which minimized the effect of diet. However, dogs ingest more 
environmental microbes than humans because of their grooming habits, which 
might affect their fecal microbiome. Dogs living in big cities are often exposed 
to many different environments and a wide range of microbes, which might 
affect the microbial diversity. 
Pre- and postnatal treatment with the probiotic La1 did not alter the 
composition of the fecal microbiome or diversity in either puppies or bitches. 
This is in accordance with results from the study of Garcia-Mazcorro et al. 
(2011), they could not observe any changes in the fecal microbiome of healthy 
adult dogs (n=12) after 3 weeks of treatment with a multi-species symbiotic 
(Proviable®-DC). Roos et al. (2013) treated infants with Lactobacillus reuteri 
for three weeks and could not detect any significant changes in the composition 
of their fecal microbiome. However, the fecal microbiome may not be a 
representative marker to display how the microbiome in different parts of the 
gut is affected by the treatment. Samples from different parts of the gut would 
be needed to answer that question. Beside the absence of impact on the 
intestinal microbiome, probiotic supplementation did not affect the levels of 
serum IgA and fecal IgA in our study, which is in accordance with the findings 
of Garcia-Mazcorro et al. (2011). Benyacoub et al. (2003) treated laboratory 
dogs with Enterococcus faecium (SF68) daily from weaning up to one year of 
age. They showed that the treatment increased vaccine (CDV) response and 
amount of circulating IgA and fecal IgA, indicating an immune-stimulatory 
effect. However, we used another probiotic strain and a shorter treatment 
period which might account for our absence of a treatment effect. 
5.6 Strengths and limitations  
The number of dogs in the insurance database was large, the high statistical 
power made it well suited to describe the occurrence of disease and death 
across breeds. The study population with dogs from the Swedish Armed Forces 
kennel included a large number of dogs born and raised under well-controlled 
conditions with standardized daily routines, diet, deworming and vaccination 
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schedules. Additionally, all samples were collected by the same person and 
analysed at the same laboratory, minimizing human induced variation.  From 8 
weeks of age, puppies lived with families which resulted in an increase in the 
variation arising from environmental factors. These results thereby would be 
more applicable to pet dogs living in the society as compared to data from 
laboratory dogs.  
The insurance database used for our epidemiological study was developed 
to register claims, and it cannot be considered a perfect source of information 
on the disease prevalence. Veterinarians assign diagnoses using a standardized 
diagnostic registry, providing a level of consistency, but their underlying 
accuracy is unknown. In this study, only the first veterinary claim for each 
animal has been included, which is most appropriate for examining and 
comparing risk across breeds, but underestimates the entire burden of disease, 
in that, individual dogs with chronic conditions might have many veterinary 
visits over the course of their lives. So, given that these are data from one 
country, and there are limitations of the insurance database, exact rates and 
risks should be extrapolated cautiously.  
Limitations of the study in paper II and III include the long time interval 
between first and second sample collection in puppies, the differences different 
length of the lactation period between litters, and too short treatment period in 
puppies. The treatment of puppies could have been more effective if started at 
birth, and in a larger study population with enough statistical power. That 
might have made it possible to detect the effect of probiotic treatment upon 
outcome of immune-related disorders. Biopsies from the small intestine would 
also give valuable information regarding the effects of probiotic treatment 
upon the gut microbiome.  
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6 Future perspectives 
Prevalence of immune-related disorders, such as allergies, is an increasing 
problem in dogs as well as in man living in industrialized countries. The 
exposure of microorganisms early in life in order to stimulate the immune 
system, and thereby preventing immune-related disorders, is an interesting area 
of research that, besides improving the immune system in certain breeds (i.e. 
GSD) predisposed to immune-related disorders also might shed light on 
possibilities for interventions of comparative interest.  
Further studies should be focused on investigating immune function in GSD 
and searching for genes involved in certain immune-related disorders within 
the breed. Molecular genetic studies would give more information regarding 
the genetics as a reason for variation in immunologic parameters as well as the 
gut microbiome. 
The next generation sequencing has given us great possibilities to discover 
the gut microbiome in dogs. Little is known about the clinical importance of 
different bacteria and it´s relation to immune-related disorders. Further studies 
should focus on detecting differences in establishment of the gut microbiome 
between dogs developing immune-related disorders and those that remain 
healthy. With the knowledge about these differences in mind, a probiotic 
adapted for these conditions could then be chosen. Parallel to these studies, and 
irrespective of microbiome data, probiotic strains with immunologically 
important properties should be identified and tested in clinical trials. These 
trials could be tested during pregnancy and lactation as wells as treatment of 
the puppies directly from birth and where gut microbiome are investigated in 
different parts of the intestine through biopsies. Clinical trials with a larger 
study population than we studied here, or in a population with higher 
prevalence of immune-related disorders, would make it possible to reveal the 
effect on early probiotic treatment upon the prevalence of immune-related 
disorders. 
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7 Summary and concluding remarks 
In an epidemiological study based on insurance data we described a breed-
specific pattern of diseases in GSDs and confirmed that the GSD is 
predisposed to immune-related disorders such as allergies, circumanal fistulae 
and exocrine pancreas atrophy. These disorders are common causes of both 
morbidity and mortality in GSDs. With that in mind, we used this breed in a 
large prospective study including 30 GSD bitches and their entire litters, in 
order to follow changes in fecal and serum immunoglobulins from birth to 
young adult age and the relationship between dams and their offspring. 
The levels of serum IgE, serum IgA and fecal IgA increased from seven 
weeks of age and were then stabilized at one year of age, there was no 
relationship in immunoglobulin concentrations between bitches and their 
puppies when the puppies were seven weeks old. We showed that dogs with 
high fecal IgA had a better vaccine response indicating a favorable systemic 
immune status.   
In these 30 litters of GSD we also described the composition of gut 
microbiome in dogs and how it changes in different life stages including 
pregnancy, lactation and growth. We found profound differences between 
mothers and young dogs, with highest similarity 7 weeks postpartum. Litter 
mates had a more similar fecal microbiome compared to unrelated dogs. The 7 
weeks old puppies were no more similar to the mothers than to unrelated 
bitches at partum. However, the puppies were significantly more similar to 
their mothers than to unrelated bitches at 7 weeks postpartum. We observed a 
change in the relative abundance of different bacteria during lactation, and an 
increase of diversity from pregnancy to end of lactation. We also found that the 
diversity of fecal microbiome was affected by living environment (if the dogs 
grew up on the countryside, in a small city or big city) but we were unable to 
demonstrate an effect of pre- and postnatal exposure to the chosen strain of 
probiotics. 
Our findings provide a better understanding of the canine fecal microbiome 
and immunoglobulins in growing dogs as well as in pregnant and lactating 
bitches, but also the environmental influence upon these systems. Our results 
provide information to an area within canine microbiology and immunology 
which is not studied before -this is the first study to describe the gut 
microbiome as well as immunoglobulins (and their relation to each other) in 
pregnant and lactating bitches and their offspring in a large well-defined study 
population. This extensive trial, with a large study population, born and raised 
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under controlled conditions, provided us with a large amount of  data, useful 
for further research on the relationship between the microbiome influences at 





I en epidemiologisk studie baserad på försäkringsdata undersöktes 
sjukdomsmönstret hos schäferhundar, varvid en predisposition för olika 
immunrelaterade sjukdomar kunde identifieras. I en stor prospektiv studie med 
30 schäfertikar och deras kullar, studerades immunförsvaret vidare i syfte att 
följa förändringar i immunoglobuliner från födsel upp till ung vuxen ålder samt 
förhållandet mellan dessa hos tik och avkomma.  
Koncentrationen av IgA och IgE serum samt fecalt IgA ökade från sju 
veckors ålder och stabiliserades vid ett års ålder. Något samband avseende 
immunoglobulinkoncentrationer mellan tikarna och deras sju veckor gamla 
valpar kunde inte påvisas. Hundar med höga nivåer av fecal IgA visade sig ha 
bättre vaccinationsrespons, vilket kan indikera en bättre systemisk immunstatus 
hos dessa individer. 
I de 30 schäferkullar som studerades analyserades även tarmflorans 
sammansättning och hur den förändras i olika livsstadier såsom dräktighet, 
digivning och tillväxt. Tydliga skillnader i tarmfloran mellan mödrar och 
unghundar kunde påvisas, medan den var mer lika mellan mödrarna och de sju 
veckor gamla valparna. Tarmfloran var också mer likartad bland kullsyskonen 
jämfört med obesläktade hundar. De sju veckor gamla valparnas tarmflora var 
inte mer lika de nyvalpade mödrarnas tarmflora än obesläktade tikar. Däremot 
var de sju veckor gamla valparnas tarmflora signifikant mer lika deras mödrar 
än de obesläktade tikarna sju veckor efter valpning. En skillnad i den relativa 
förekomsten av olika bakterier under digivning kunde identifieras, liksom en 
ökning av diversitet från dräktighet till slutet av digivningen. Vi såg även att 
tarmflorans diversitet påverkades av uppväxtmilön (om hundarna växte upp på 
landet, i en småstad eller i en storstad) men vi kunde inte visa någon effekt av 
probiotika-tillskott under dräktighet, digivning och första levnadstiden. 
Våra fynd bidrar till en bättre förståelse för hundens tarmflora och 
immunoglobuliner hos såväl växande hundar som dräktiga och digivande tikar, 
men även hur dessa system påverkas av olika miljöfaktorer. Våra resultat tillför 
information till ett område inom hundars mikrobiologi och immunologi som 
inte studerats tidigare, det här är den första studien som beskriver tarmfloran 
samt immunoglobulinnivåer hos dräktiga och digivande tikar samt deras 
avkomma i en stor och välkontrollerad studiepopulation. 
Denna kunskap är en viktig bas för fortsatta studier av sambandet mellan 
bakteriefloran tidigt och immunförsvaret senare i livet samt av betydelse för 
utvärdering av möjligheter till preventiva åtgärder  
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